Literature DB >> 15486867

The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide.

Friedrich K Port1, Garabed Eknoyan.   

Abstract

Two initiatives were launched in the closing years of the past century with the goal of improving the treatment outcomes of patients with kidney failure: the Kidney Disease Outcomes Quality Initiative, which formed expert panels to develop evidence-based clinical practice guidelines, and the Dialysis Outcomes and Practice Patterns Study (DOPPS), which now gathers data on practice patterns in dialysis facilities in 12 countries, including the United States. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) program was established to promote worldwide coordination and integration of initiatives to develop and implement clinical practice guidelines and provides new opportunities of cooperation with the international scope of the DOPPS. Collaboration between the DOPPS and KDIGO will lead to broader dissemination of relevant information to nephrologists, health care providers, and patients. Linking the DOPPS scope of work with the KDIGO goals will help develop continuous quality improvement programs and the provision of direct feedback to participating dialysis centers throughout the world. This will establish an essential component in the translation to clinical practice of evidence-based guidelines worldwide.

Entities:  

Mesh:

Year:  2004        PMID: 15486867     DOI: 10.1053/j.ajkd.2004.08.004

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.

Authors:  Maki Shinzawa; Ryohei Yamamoto; Yasuyuki Nagasawa; Tatsuya Shoji; Yoshitsugu Obi; Tomoko Namba; Harumi Kitamura; Tetsuya Kaneko; Noriyuki Okada; Hirotsugu Iwatani; Atsushi Yamauchi; Yoshiharu Tsubakihara; Enyu Imai; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Clin Exp Nephrol       Date:  2011-11-11       Impact factor: 2.801

Review 2.  Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines.

Authors:  Satoru Kuriyama
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

3.  Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality?

Authors:  Yi Zhang; Mae Thamer; Onkar Kshirsagar; Dennis J Cotter
Journal:  Health Serv Res       Date:  2012-12-06       Impact factor: 3.402

4.  How can we achieve global equity in provision of renal replacement therapy?

Authors:  Sarah L White; Steven J Chadban; Stephen Jan; Jeremy R Chapman; Alan Cass
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

5.  Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study.

Authors:  Kazuhiko Tsuruya; Shingo Fukuma; Takafumi Wakita; Toshiharu Ninomiya; Masaharu Nagata; Hisako Yoshida; Satoru Fujimi; Yutaka Kiyohara; Takanari Kitazono; Kazuhiro Uchida; Tomoko Shirota; Tadao Akizawa; Takashi Akiba; Akira Saito; Shunichi Fukuhara
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

6.  Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPS.

Authors:  Xinju Zhao; Qingyu Niu; Liangying Gan; Fan Fan Hou; Xinling Liang; Zhaohui Ni; Xiaonong Chen; Yuqing Chen; Keith McCullough; Bruce Robinson; Li Zuo
Journal:  BMC Nephrol       Date:  2022-01-03       Impact factor: 2.388

Review 7.  Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models.

Authors:  Pengfei Yu; Zhongping Duan; Shuang Liu; Ivan Pachon; Jianxing Ma; George P Hemstreet; Yuanyuan Zhang
Journal:  Micromachines (Basel)       Date:  2021-12-21       Impact factor: 2.891

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.